141 related articles for article (PubMed ID: 38140954)
21. Oral ribose supplementation in dystroglycanopathy: A single case study.
Thewissen RMJ; Post MA; Maas DM; Veizaj R; Wagenaar I; Alsady M; Kools J; Bouman K; Zweers H; Meregalli PG; van der Kooi AJ; van Doorn PA; Groothuis JT; Lefeber DJ; Voermans NC
JIMD Rep; 2024 May; 65(3):171-181. PubMed ID: 38736632
[TBL] [Abstract][Full Text] [Related]
22. Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-Mannosylation.
Riemersma M; Froese DS; van Tol W; Engelke UF; Kopec J; van Scherpenzeel M; Ashikov A; Krojer T; von Delft F; Tessari M; Buczkowska A; Swiezewska E; Jae LT; Brummelkamp TR; Manya H; Endo T; van Bokhoven H; Yue WW; Lefeber DJ
Chem Biol; 2015 Dec; 22(12):1643-52. PubMed ID: 26687144
[TBL] [Abstract][Full Text] [Related]
23. ISPD Overexpression Enhances Ribitol-Induced Glycosylation of α-Dystroglycan in Dystrophic FKRP Mutant Mice.
Cataldi MP; Blaeser A; Lu P; Leroy V; Lu QL
Mol Ther Methods Clin Dev; 2020 Jun; 17():271-280. PubMed ID: 31988979
[TBL] [Abstract][Full Text] [Related]
24. Mammalian O-mannosyl glycans: Biochemistry and glycopathology.
Endo T
Proc Jpn Acad Ser B Phys Biol Sci; 2019; 95(1):39-51. PubMed ID: 30643095
[TBL] [Abstract][Full Text] [Related]
25. Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice.
Cataldi MP; Lu P; Blaeser A; Lu QL
Nat Commun; 2018 Aug; 9(1):3448. PubMed ID: 30150693
[TBL] [Abstract][Full Text] [Related]
26. Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members.
O'connor T; Ireland LS; Harrison DJ; Hayes JD
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):487-504. PubMed ID: 10510318
[TBL] [Abstract][Full Text] [Related]
27. Ribitol enhances matriglycan of α-dystroglycan in breast cancer cells without affecting cell growth.
Lu PJ; Tucker JD; Branch EK; Guo F; Blaeser AR; Lu QL
Sci Rep; 2020 Mar; 10(1):4935. PubMed ID: 32188898
[TBL] [Abstract][Full Text] [Related]
28. Crystallographic analysis of TarI and TarJ, a cytidylyltransferase and reductase pair for CDP-ribitol synthesis in Staphylococcus aureus wall teichoic acid biogenesis.
Li FKK; Gale RT; Petrotchenko EV; Borchers CH; Brown ED; Strynadka NCJ
J Struct Biol; 2021 Jun; 213(2):107733. PubMed ID: 33819634
[TBL] [Abstract][Full Text] [Related]
29. Reduction precedes cytidylyl transfer without substrate channeling in distinct active sites of the bifunctional CDP-ribitol synthase from Haemophilus influenzae.
Zolli M; Kobric DJ; Brown ED
Biochemistry; 2001 Apr; 40(16):5041-8. PubMed ID: 11305920
[TBL] [Abstract][Full Text] [Related]
30. Glycobiology of α-dystroglycan and muscular dystrophy.
Endo T
J Biochem; 2015 Jan; 157(1):1-12. PubMed ID: 25381372
[TBL] [Abstract][Full Text] [Related]
31. Biosynthetic Mechanisms and Biological Significance of Glycerol Phosphate-Containing Glycan in Mammals.
Imae R; Manya H; Endo T
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771084
[TBL] [Abstract][Full Text] [Related]
32. Expression in retinal neurons of fukutin and FKRP, the protein products of two dystroglycanopathy-causative genes.
Haro C; Uribe ML; Quereda C; Cruces J; Martín-Nieto J
Mol Vis; 2018; 24():43-58. PubMed ID: 29416295
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of CDP-activated ribitol for teichoic acid precursors in Streptococcus pneumoniae.
Baur S; Marles-Wright J; Buckenmaier S; Lewis RJ; Vollmer W
J Bacteriol; 2009 Feb; 191(4):1200-10. PubMed ID: 19074383
[TBL] [Abstract][Full Text] [Related]
34. Enhancing the flux of D-glucose to the pentose phosphate pathway in Saccharomyces cerevisiae for the production of D-ribose and ribitol.
Toivari MH; Maaheimo H; Penttilä M; Ruohonen L
Appl Microbiol Biotechnol; 2010 Jan; 85(3):731-9. PubMed ID: 19711072
[TBL] [Abstract][Full Text] [Related]
35. Ribitol and flavinogenesis in Eremothecium ashbyii.
Mehta SU; Mattoo AK; Modi VV
Biochem J; 1972 Nov; 130(1):159-66. PubMed ID: 4144070
[TBL] [Abstract][Full Text] [Related]
36. Cancer Malignancy Is Correlated with Upregulation of PCYT2-Mediated Glycerol Phosphate Modification of α-Dystroglycan.
Umezawa F; Natsume M; Fukusada S; Nakajima K; Yamasaki F; Kawashima H; Kuo CW; Khoo KH; Shimura T; Yagi H; Kato K
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743105
[TBL] [Abstract][Full Text] [Related]
37. Structure and functions of linkage unit intermediates in the biosynthesis of ribitol teichoic acids in Staphylococcus aureus H and Bacillus subtilis W23.
Yokoyama K; Miyashita T; Araki Y; Ito E
Eur J Biochem; 1986 Dec; 161(2):479-89. PubMed ID: 3096735
[TBL] [Abstract][Full Text] [Related]
38. Yarrowia lipolytica dehydrogenase/reductase: an enzyme tolerant for lipophilic compounds and carbohydrate substrates.
Napora K; Wrodnigg TM; Kosmus P; Thonhofer M; Robins K; Winkler M
Bioorg Med Chem Lett; 2013 Jun; 23(11):3393-5. PubMed ID: 23608762
[TBL] [Abstract][Full Text] [Related]
39. Temporal requirement of dystroglycan glycosylation during brain development and rescue of severe cortical dysplasia via gene delivery in the fetal stage.
Sudo A; Kanagawa M; Kondo M; Ito C; Kobayashi K; Endo M; Minami Y; Aiba A; Toda T
Hum Mol Genet; 2018 Apr; 27(7):1174-1185. PubMed ID: 29360985
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
